Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Antimicrobial Agents and Chemotherapy|June 1, 2017
Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA PolymeraseMaryam Ehteshami, Longhu Zhou, Sheida Amiralaei, et al.Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Cross-sectional IgM and IgG profiles in SARS-CoV-2 infectionTugba Ozturk, J Christina Howell, Karima Benameur, et al.Antimicrobial Agents and Chemotherapy|November 13, 2019
Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses <i>In Vitro</i> and in Humanized MiceFranck Amblard, Sebastien Boucle, Leda Bassit, et al.Emerging Infectious Diseases|August 29, 2020
Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020William T Hu, J Christina Howell, Tugba Ozturk, et al.Antimicrobial Agents and Chemotherapy|May 25, 2016
Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094Maryam Ehteshami, Sijia Tao, Tugba Ozturk, et al.Frontiers in Medicine|December 20, 2024
Identifying sex similarities and differences in structure and function of the sinoatrial node in the mouse heartZeyuan Yin, Eleonora Torre, Manon Marrot, et al.Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Dominant extrafollicular B cell responses in severe COVID-19 disease correlate with robust viral-specific antibody production but poor clinical outcomesMatthew Woodruff, Richard Ramonell, Kevin Cashman, et al.Nature Immunology|October 8, 2020
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19Matthew C Woodruff, Richard P Ramonell, Doan C Nguyen, et al.Pageof 2